Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies

Rhea-AI Summary

Marker Therapeutics highlights its technology in a webinar on CAR-T cell therapy organized by WBB Securities. The webinar featured experts discussing the science, clinical applications, and market growth of CAR-T therapy. WBB Securities plays a crucial role in connecting investors with healthcare developments and there is growing investor interest in CAR-T therapy.

Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights its technology during a recently held, 75-minute Demi-Colton Virtual Salon/Webinar on cell therapy and CAR-T, a breakthrough cancer treatment that modifies a patient's own T cells to fight cancer.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• WBB Securities, an investment bank specializing in biotechnology, medical devices and life sciences, successfully organized a webinar focusing on the potential of Chimeric Antigen Receptor T-Cells (CAR-T) therapy in the future of cancer treatment.
• The webinar, organized by CEO Steve Brozak, DMH featured distinguished speakers and experts in the field of CAR-T Cell therapy who provided insights into the science behind the therapy, its clinical applications, and potential market growth.
• The positive response to the event underscores WBB Securities' role in connecting investors with key developments in the healthcare industry and a growing interest in CAR-T Cell therapy among the investor community.

Click image above to view full announcement.

---

WBB Securities

The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

Contacts:

Henry Bassman
9085229212
hbassman@wbbsec.com

Source: WBB Securities

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177588

FAQ

What was the focus of the webinar organized by WBB Securities?

The webinar focused on the potential of Chimeric Antigen Receptor T-Cells (CAR-T) therapy in the future of cancer treatment.

Who organized the webinar?

The webinar was organized by WBB Securities.

What is CAR-T therapy?

CAR-T therapy is a breakthrough cancer treatment that modifies a patient's own T cells to fight cancer.

What role does WBB Securities play in connecting investors with healthcare developments?

WBB Securities plays a crucial role in connecting investors with key developments in the healthcare industry.

Is there growing investor interest in CAR-T therapy?

Yes, there is growing interest in CAR-T therapy among the investor community.